BioCentury | Aug 16, 2017
Emerging Company Profile

Aiming horizontal

...into strains already deemed safe for humans by FDA . According to CEO Jeanette Mucha, SciBac’s...
...a phenotype that we want and a strain that we want to move it into.” SciBac...
...CSE:NZYM B), Bagsværd, Denmark SciBac Inc., Milpitas, Calif. Michael Leviten, Senior Writer Aeruguard DiffiKil Bristol-Myers Squibb Co. Merck & Co. Inc. Novozymes A/S SciBac Inc. Clostridium Cystic...
BioCentury | Apr 21, 2017
Financial News

Thiel Foundation's Breakout Labs awards funding

...13, the companies each received an undisclosed award from the Thiel Foundation’s Breakout Labs program. SciBac...
...Mass. LogicInk, San Francisco, Calif. SciBac Inc. , Milpitas, Calif. Thiel Foundation , San Francisco, Calif. Alicia Parker SciBac Inc. Thiel...
Items per page:
1 - 2 of 2
BioCentury | Aug 16, 2017
Emerging Company Profile

Aiming horizontal

...into strains already deemed safe for humans by FDA . According to CEO Jeanette Mucha, SciBac’s...
...a phenotype that we want and a strain that we want to move it into.” SciBac...
...CSE:NZYM B), Bagsværd, Denmark SciBac Inc., Milpitas, Calif. Michael Leviten, Senior Writer Aeruguard DiffiKil Bristol-Myers Squibb Co. Merck & Co. Inc. Novozymes A/S SciBac Inc. Clostridium Cystic...
BioCentury | Apr 21, 2017
Financial News

Thiel Foundation's Breakout Labs awards funding

...13, the companies each received an undisclosed award from the Thiel Foundation’s Breakout Labs program. SciBac...
...Mass. LogicInk, San Francisco, Calif. SciBac Inc. , Milpitas, Calif. Thiel Foundation , San Francisco, Calif. Alicia Parker SciBac Inc. Thiel...
Items per page:
1 - 2 of 2